sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has made a disclosure under Rule 8.3 of the Irish Takeover Panel Act, 1997. This involves its position in Mural Oncology plc. The information was released on September 9, 2025.
The disclosure identifies The Vanguard Group as holding interests of 4.47% in $0.01 ordinary shares of Mural Oncology plc. However, it notes no positions in cash-settled or stock-settled derivatives. A recent sale involved 16 ordinary shares at $2.07 per share.
The disclosure reports no indemnity or option arrangement agreements related to the securities of Mural Oncology and no supplemental forms were attached. Shawn Acker is listed as the contact person for this disclosure.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.